Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Wardlow

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Chromatography|March 16, 1990
Sensitive analysis of plasma physostigmine levels using dual-cell electrochemistry in the redox modeS Knapp, M L Wardlow, L J Thal
Pediatric Neurology|November 1, 1991
Changes in CSF neurotransmitters in infantile spasmsP J Langlais, M L Wardlow, H Yamamoto
Neurobiology of Learning and Memory|April 10, 1999
Deficit in selective and divided attention associated with cholinergic basal forebrain immunotoxic lesion produced by 192-saporin; motoric/sensory deficit associated with Purkinje cell immunotoxic lesion produced by OX7-saporinJ J Waite, M L Wardlow, A E Power
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1981
The presence of platelet-activating factor (PAF) in normal human mixed salivaC P Cox, M L Wardlow, R Jorgensen, et al.
Experimental Neurology|December 1, 1994
Behavioral and biochemical consequences of combined lesions of the medial septum/diagonal band and nucleus basalis in the rat when ibotenic acid, quisqualic acid, and AMPA are usedJ J Waite, A D Chen, M L Wardlow, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1991
Correlation between plasma physostigmine concentrations and percentage of acetylcholinesterase inhibition over time after controlled release of physostigmine in volunteer subjectsS Knapp, M L Wardlow, K Albert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1986
Substrate specificity and partial characterization of the PAF-acylhydrolase in human serum that rapidly inactivates platelet-activating factorM L Wardlow, C P Cox, K E Meng, et al.
Experimental Hematology|March 1, 1979
Abnormal immunoglobulins in severe combined immunodeficiency: analysis by immunoelectrophoresis and SDS-polyacrylamide gel electrophoresisM L Wardlow, F Hariman, B S Criswell, et al.
Federation Proceedings|November 1, 1983
Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factorR S Farr, M L Wardlow, C P Cox, et al.
Neuroscience Letters|March 14, 1994
Time course of cholinergic and monoaminergic changes in rat brain after immunolesioning with 192 IgG-saporinJ J Waite, M L Wardlow, A C Chen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Chromatography|March 16, 1990
Sensitive analysis of plasma physostigmine levels using dual-cell electrochemistry in the redox modeS Knapp, M L Wardlow, L J Thal
Pediatric Neurology|November 1, 1991
Changes in CSF neurotransmitters in infantile spasmsP J Langlais, M L Wardlow, H Yamamoto
Neurobiology of Learning and Memory|April 10, 1999
Deficit in selective and divided attention associated with cholinergic basal forebrain immunotoxic lesion produced by 192-saporin; motoric/sensory deficit associated with Purkinje cell immunotoxic lesion produced by OX7-saporinJ J Waite, M L Wardlow, A E Power
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1981
The presence of platelet-activating factor (PAF) in normal human mixed salivaC P Cox, M L Wardlow, R Jorgensen, et al.
Experimental Neurology|December 1, 1994
Behavioral and biochemical consequences of combined lesions of the medial septum/diagonal band and nucleus basalis in the rat when ibotenic acid, quisqualic acid, and AMPA are usedJ J Waite, A D Chen, M L Wardlow, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1991
Correlation between plasma physostigmine concentrations and percentage of acetylcholinesterase inhibition over time after controlled release of physostigmine in volunteer subjectsS Knapp, M L Wardlow, K Albert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1986
Substrate specificity and partial characterization of the PAF-acylhydrolase in human serum that rapidly inactivates platelet-activating factorM L Wardlow, C P Cox, K E Meng, et al.
Experimental Hematology|March 1, 1979
Abnormal immunoglobulins in severe combined immunodeficiency: analysis by immunoelectrophoresis and SDS-polyacrylamide gel electrophoresisM L Wardlow, F Hariman, B S Criswell, et al.
Federation Proceedings|November 1, 1983
Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factorR S Farr, M L Wardlow, C P Cox, et al.
Neuroscience Letters|March 14, 1994
Time course of cholinergic and monoaminergic changes in rat brain after immunolesioning with 192 IgG-saporinJ J Waite, M L Wardlow, A C Chen, et al.
Pageof 2